Correction to “Treatment-Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet-Rich Plasma in Bladder Pain Syndrome”

IF 1.8 4区医学 Q3 UROLOGY & NEPHROLOGY

LUTS: Lower Urinary Tract Symptoms Pub Date : 2026-06-02 DOI:10.1111/luts.70070

{"title":"Correction to “Treatment-Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet-Rich Plasma in Bladder Pain Syndrome”","authors":"","doi":"10.1111/luts.70070","DOIUrl":null,"url":null,"abstract":"W. R. Yu, T. C. Hsieh, Y. H. Wu, and H. C. Kuo, “Treatment-Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet-Rich Plasma in Bladder Pain Syndrome,” Lower Urinary Tract Symptoms 18, no.2 (March 2026): e70057, https://doi.org/10.1111/luts.70057.The Institutional Review Board approval number was incorrectly stated as “IRB113-015-B” instead of “IRB115-015-B” in subsection 2.1 and in the Ethics Statement section.Accordingly, the first sentence of the third paragraph in subsection 2.1 should read: “The study protocol was approved by the Research Ethics Committee of Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (IRB115-015-B).”The Ethics Statement section should read:Ethics StatementThe Research Ethics Committee of the Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, approved this study (IRB115-015-B).We apologize for this error.","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":"18 4","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2026-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/luts.70070","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"LUTS: Lower Urinary Tract Symptoms","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/luts.70070","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

W. R. Yu, T. C. Hsieh, Y. H. Wu, and H. C. Kuo, “Treatment-Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet-Rich Plasma in Bladder Pain Syndrome,” Lower Urinary Tract Symptoms 18, no.2 (March 2026): e70057, https://doi.org/10.1111/luts.70057.

The Institutional Review Board approval number was incorrectly stated as “IRB113-015-B” instead of “IRB115-015-B” in subsection 2.1 and in the Ethics Statement section.

Accordingly, the first sentence of the third paragraph in subsection 2.1 should read: “The study protocol was approved by the Research Ethics Committee of Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (IRB115-015-B).”

The Ethics Statement section should read:

Ethics Statement

The Research Ethics Committee of the Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, approved this study (IRB115-015-B).

We apologize for this error.

查看原文本刊更多论文

对“膀胱疼痛综合征患者膀胱内肉毒杆菌毒素A和富血小板血浆反应与治疗特异性临床和尿液生物标志物特征相关”的更正。

余文荣，谢廷春，吴玉华，郭洪昌，“膀胱内肉毒毒素A和富血小板血浆对膀胱疼痛综合征的治疗特异性临床和尿液生物标志物特征的影响”，下尿路症候群18，第2期（2026年3月）：e70057, https://doi.org/10.1111/luts.70057.The机构审查委员会批准号在第2.1小节和伦理声明部分中错误地写成“IRB113-015-B”而不是“IRB115-015-B”。因此，第2.1小节第三段第一句应该是：“本研究方案经佛教慈济基金会花莲慈济医院研究伦理委员会（IRB115-015-B）批准。”伦理声明部分应阅读：伦理声明佛教慈济基金会慈济医院研究伦理委员会批准本研究（IRB115-015-B）。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

LUTS: Lower Urinary Tract Symptoms UROLOGY & NEPHROLOGY-

CiteScore

3.00

自引率

7.70%

发文量

审稿时长

>12 weeks

期刊介绍： LUTS is designed for the timely communication of peer-reviewed studies which provides new clinical and basic science information to physicians and researchers in the field of neurourology, urodynamics and urogynecology. Contributions are reviewed and selected by a group of distinguished referees from around the world, some of whom constitute the journal''s Editorial Board. The journal covers both basic and clinical research on lower urinary tract dysfunctions (LUTD), such as overactive bladder (OAB), detrusor underactivity, benign prostatic hyperplasia (BPH), bladder outlet obstruction (BOO), urinary incontinence, pelvic organ prolapse (POP), painful bladder syndrome (PBS), as well as on other relevant conditions. Case reports are published only if new findings are provided. LUTS is an official journal of the Japanese Continence Society, the Korean Continence Society, and the Taiwanese Continence Society. Submission of papers from all countries are welcome. LUTS has been accepted into Science Citation Index Expanded (SCIE) with a 2011 Impact Factor.